Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | S214Pfs*16 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM S214Pfs*16 indicates a shift in the reading frame starting at amino acid 214 and terminating 16 residues downstream causing a premature truncation of the 3056 amino acid Atm protein (UniProt.org). S214Pfs*16 has not been characterized, however, due to the effects of other truncation mutations downstream of S214 (PMID: 16603769), is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM S214fs ATM S214Pfs*16 |
Transcript | NM_000051.4 |
gDNA | chr11:g.108244096delT |
cDNA | c.640delT |
Protein | p.S214Pfs*16 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000051.4 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_047426981.1 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108244096delT | c.640delT | p.S214Pfs*16 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
ATM S214Pfs*16 | colorectal cancer | sensitive | ART0380 | Preclinical - Pdx | Actionable | In a preclinical study, ART0380 inhibited tumor growth in a colorectal cancer patient-derived xenograft (PDX) model harboring ATM S214Pfs*16 (PMID: 38416404). | 38416404 |